Description

Established in 1976 and headquartered in Taipei, Taiwan, Maywufa Company Ltd. is a diversified enterprise primarily known for producing and marketing a range of consumer goods in Taiwan. These include its proprietary Maywufa-branded hair and skincare solutions, as well as broader health care products, food supplements, and the specialized Mustela line for maternal and infant skincare. Beyond consumer offerings, Maywufa plays a significant role in the pharmaceutical and medical device sectors. Its portfolio features specific medical solutions such as the PG2 Lyophilized injection for managing cancer-related fatigue, the AmCad-UT Detection device for advanced thyroid cancer screening via ultrasound, Bio-Three tablets targeting common digestive ailments like mild diarrhea, abdominal pain, and constipation, and Cerebrolysin, a vital nutritional supplement for individuals facing severe dietary deficiencies, impaired protein metabolism, or recovery from trauma and malnutrition. The company further solidifies its market presence through the distribution of various pharmaceutical products and by operating and managing its network of retail pharmacies under the 'Pharmacy Franchise' brand.